Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1998 Mar;89(3):291–298. doi: 10.1111/j.1349-7006.1998.tb00561.x

Up‐regulation of CD44 Variant Exon Expression in Endometrial Carcinomas: Analysis of mRNA and Protein Isoforms, and Relation to Clinicopathological Factors

Makoto Saegusa 1,✉, Isao Okayasu 1
PMCID: PMC5921797  PMID: 9600123

Abstract

In order to clarify the relation between expression of individual CD44 variant exons and tumor progression, 34 endometrial carcinomas (endometrioid type) were investigated, as well as 27 samples of normal endometrium, using a combination of reverse transcription‐polymerase chain reaction (RT‐PCR) and Southern blot hybridization (SBH). Western blotting was also performed for comparison of protein levels with the results of the RT‐PCR/SBH methods. Analysis of gross CD44 splicing patterns demonstrated high‐level expression of variant isoforms in endometrial carcinomas as compared with normal endometrium. Exon‐specific RT‐PCR/SBH assays revealed large, abundant transcripts of individual variant exons, in particular v3, v4, and v5, in tumors, but these isoforms were also expressed in normal endometria, suggesting a lack of tumor‐specificity. No individual CD44 variant transcripts were associated with any of the prognostic factors investigated. Parallel observations showed variant CD44 transcripts to be more readily detectable than protein isoforms in the same samples. These findings indicate that in endometrial carcinomas, expression of individual variant CD44 exons is markedly up‐regulated, but this molecule may not be useful as a consistent indicator of tumor progression.

Keywords: CD44, Endometrial carcinoma, RT‐PCR, Southern blot, Western blot

Full Text

The Full Text of this article is available as a PDF (620.0 KB).

REFERENCES

  • 1. ) Haynes , B. F. , Telen , M. J. , Hale , L. P. and Denning , S. M.CD44: a molecule involved in leukocyte adherence and T‐cell activation . Immunol. Today , 10 , 423 – 428 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Underhill , C.CD44: the hyaluronan receptor . J. Cell Sci. , 103 , 293 – 298 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Gunthert , U.CD44: a multitude of isoforms with diverse functions . Curr. Top. Microbiol. Immunol. , 184 , 47 – 63 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Lesley , J. , Hyman , R. and Kincade , P. W.CD44 and its interaction with extracellular matrix . Adv. Immunol. , 54 , 271 – 335 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Screaton , G. R. , Bell , M. V. , Bell , J. I. and Jackson , D. G.The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp‐1 (CD44) homing receptor . J. Biol. Chem. , 268 , 12235 – 12238 ( 1993. ). [PubMed] [Google Scholar]
  • 6. ) Tolg , C. , Hofman , M. , Herrlich , P. and Ponta , H.Splicing choice from ten variant exons establishes CD44 variability . Nucleic Acids Res. , 21 , 1225 – 1229 ( 1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. ) Fox , S. B. , Fawcett , J. , Jackson , D. G. , Collins , I. , Gatter , K. C. , Harris , A. L. , Gearing , A. and Simmons , D. L.Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms . Cancer Res. , 54 , 4539 – 4546 ( 1994. ). [PubMed] [Google Scholar]
  • 8. ) Mackay , C. R. , Terpe , H.‐J. , Stauder , R. , Marston , W. L. , Stark , H. and Gunthert , U.Expression and modulation of CD44 variant isoforms in humans . J. Cell Biol. , 124 , 71 – 82 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. ) Stamenkovic , I. , Aruffo , A. , Amiot , M. and Seed , B.The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate‐bearing cells . EMBO J. , 10 , 343 – 348 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. ) Rudy , W. , Hofmann , M. , Schwartz‐Albeiz , R. , Zoller , M. , Heider , K. M. , Ponta , H. and Herrlich , P.Two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behaviour . Cancer Res. , 53 , 1262 – 1268 ( 1993. ). [PubMed] [Google Scholar]
  • 11. ) Reber , S. , Matzku , S. , Gunthert , H. , Ponta , P. , Herrlich , P. and Zoller , M.Retardation of metastatic tumor growth after immunisation with metastasis‐specific monoclonal antibodies . Int. J. Cancer , 46 , 919 – 927 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Kaufmann , M. , Heider , K. H. , Sinn , H. P. , von Minckwitz , G. , Ponta , H. and Herrlich , P.CD44 variant exon epitopes in primary breast cancer and length of survival . Lancet , 345 , 615 – 619 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Matsumura , Y. , Hanbury , D. , Smith , J. and Tarin , D.Non‐invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells . Br. Med. J. , 308 , 619 – 624 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. ) Tanabe , K. K. , Ellis , L. M. and Saya , H.Expression of CD44R1 adhesion molecule in colon carcinomas and metastases . Lancet , 341 , 725 – 726 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Matsumura , Y. , Sugiyama , M. , Matsumura , S. , Hayle , A. J. , Robinson , P. , Smith , J. C. and Tarin , D.Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities . J. Pathol. , 177 , 11 – 20 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 16. ) Yoshida , K. , Bolodeoku , J. , Sugino , T. , Goodison , S. , Matsumura , Y. , Warren , B. F. , Toge , T. , Tahara , E. and Tarin , D.Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumors . Cancer Res. , 55 , 4273 – 4277 ( 1995. ). [PubMed] [Google Scholar]
  • 17. ) Fujita , N. , Yaegashi , N. , Ide , Y. , Sato , S. , Nakamura , M. , Ishiwata , I. and Yajima , A.Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph‐vascular space involvement of cancer cells . Cancer Res. , 54 , 3922 – 3928 ( 1994. ). [PubMed] [Google Scholar]
  • 18. ) Creasman , W. T.Announcement, FIGO stages: 1988 revisions . Gynecol. Oncol. , 35 , 125 – 127 ( 1989. ). [Google Scholar]
  • 19. ) Matsumura , Y. and Tarin , D.Significance of CD44 gene products for cancer diagnosis and disease evaluation . Lancet , 340 , 1053 – 1058 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Gotley , D. C. , Fawcett , J. , Walsh , M. D. , Reeder , J. A. , Simmons , D. L. and Antalis , T. M.Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer . Br. J. Cancer , 74 , 342 – 351 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. ) Horstmann , M. A. , Posl , M. , Scholz , R. B. , Anderegg , B. , Simon , P. , Baumgaertl , K. , Delling , G. and Kabisch , H.Frequent reduction or loss of DCC gene expression in human osteosarcoma . Br. J. Cancer , 75 , 1309 – 1317 ( 1997. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. ) Laemmli , U. K.Cleavage of structural proteins during the assembly of the head of bacteriophage T4 . Nature , 227 , 680 – 685 ( 1970. ). [DOI] [PubMed] [Google Scholar]
  • 23. ) Herold‐Mende , C. , Seiter , S. , Born , A. , Patzelt , E. , Schupp , M. , Zoller , J. , Bosch F. X. and Zoller , M.Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck . J. Pathol. , 179 , 66 – 73 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 24. ) Seiter , S. , Tilgen , W. , Herrmann , K. , Schadendorf , D. , Patzelt , E. , Moller , P. and Zoller , M.Expression of CD44 splice variants in human skin and epidermal tumours . Virchows Arch. , 428 , 141 – 149 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 25. ) Sugiyama , M. , Woodman , A. , Sugino , T. , Crowley , S. , Ho , K. , Smith , J. , Matsumura , Y. and Tarin , D.Non‐invasive detection of bladder cancer by identification of abnormal CD44 proteins in exfoliated cancer cells in urine . J. Clin. Pathol. Mol. Pathol. , 48 , M142 – M147 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. ) Behzad , F. , Seif , M. W. , Campbell , S. and Aplin , J. D.Expression of two isoforms of CD44 in human endometrium . Biol. Reprod. , 51 , 739 – 747 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 27. ) Terpe , H. J. , Stark , H. , Prehm , P. and Günthert , U.CD44 variant isoforms are preferentially expressed in basal epithelia of non‐malignant human fetal and adult tissues . Histochemistry , 101 , 79 – 89 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 28. ) Terpe , H.‐J. , Koopmann , R. , Imhof , B. A. and Günthert , U.Expression of integrins and CD44 isoforms in non‐Hodgkin's lymphomas: CD44 variant isoforms are preferentially expressed in high‐grade malignant lymphomas . J. Pathol. , 174 , 89 – 100 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 29. ) Wielenga , V. J. M. , Heider , K.‐H. , Offerhaus , G. J. A. , Adolf , G. R. , van den Berg , F. M. , Ponta , H. , Herrlich , P. and Pals , S. T.Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression . Cancer Res. , 53 , 4754 – 4756 ( 1993. ). [PubMed] [Google Scholar]
  • 30. ) Washington , M. K. , Gottfried , M. R. and Telen , M. J.Expression of the cell adhesion molecule CD44 in gastric adenocarcinoma . Lab. Invest. , 68 , 52A ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 31. ) Gross , N. , Beretta , C. , Peruisseau , G. , Jackson , D. , Simmons , D. and Beck , D.CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation . Cancer Res. , 54 , 4238 – 4242 ( 1994. ). [PubMed] [Google Scholar]
  • 32. ) Kallakury , B. V. S. , Yang , F. , Figge , J. , Smith , K. E. , Kausik , S. J. , Tacy , N. J. , Fisher , H. A. G. , Kaufman , R. , Figge , H. and Ross , J. S.Decreased levels of CD44 protein and mRNA in prostate carcinoma: correlation with tumor grade and ploidy . Cancer , 78 , 1461 – 1469 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 33. ) Sugino , T. , Gorham , H. , Yoshida , K. , Bolodeoku , J. , Nargund , V. , Cranston , D. , Goodison , S. and Tarin , D.Progressive loss of CD44 gene expression in invasive bladder cancer . Am. J. Pathol. , 149 , 873 – 882 ( 1996. ). [PMC free article] [PubMed] [Google Scholar]
  • 34. ) Goodison , S. , Yoshida , K. , Sugino , T. , Woodman , A. , Gorham , H. , Bolodeoku , J. , Kaufmann , M. and Tarin , D.Rapid analysis of distinctive CD44 RNA splicing preferences that characterize colonic tumors . Cancer Res. , 57 , 3140 – 3144 ( 1997. ). [PubMed] [Google Scholar]
  • 35. ) Screaton , G. R. , Bell , M. V. , Jackson , D. G. , Cornelis , F. B. , Gerth , U. and Bell , J. I.Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons . Proc. Natl. Acad. Sci. USA , 89 , 12160 – 12164 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. ) Woodman , A. C. , Sugiyama , M. , Yoshida , K. , Sugino , T. , Borgya , A. , Goodison , S. , Matsumura , Y. and Tarin , D.Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms . Am. J. Pathol. , 149 , 1519 – 1530 ( 1996. ). [PMC free article] [PubMed] [Google Scholar]
  • 37. ) Dall , P. , Heider , K.‐H. , Sinn , H.‐P. , Skroch‐Angel , P. , Adolf , G. , Kaufmann , M. , Herrlich , P. and Ponta , H.Comparison of immunohistochemistry and RT‐PCR for detection of CD44v‐expression, a new prognostic factor in human breast cancer . Int. J. Cancer , 60 , 471 – 477 ( 1995. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES